MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s13277-013-1374-y

Медицинская библиотека · Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013

High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.

Buhmeida Abdelbaset, Dallol Ashraf, Merdad Adnan, Al-Maghrabi Jaudah, Gari Mamdooh A, Abu-Elmagd Muhammad M, Chaudhary Adeel G, Abuzenadah Adel M, Nedjadi Taoufik, Ermiah Eramah, Al-Thubaity Fatima, Al-Qahtani Mohammed H

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Metabolic diseases like diabetes and obesity are major risk factors for breast cancer. Aberrant expression of metabolic effectors such as fibroblast growth factor 19 (FGF19) could be therefore associated with the disease. The expression of FGF19 was examined in 193 archival breast tumor samples by immunohistochemistry and evaluated semi-quantitatively by determining the staining index and correlating it with clinicopathological parameters using Fisher's exact test. The correlation between FGF19 expression and 5-year disease-specific survival rate was determined using the univariate Kaplan-Meier analysis. The prognostic value of FGF19 expression was evaluated using the multivariate Cox regression analysis. Of the 193 tumors analyzed, 40% were classified with low FGF19 expression, whereas 60% were categorized as tumors with high FGF19 expression. There was a highly significant correlation between high FGF19 expression and patients' age (p = 0.008) as well as 5-year disease-specific survival (p = 0.001). However, FGF19 expression did not show any significant correlations with other clinicopathological parameters, including hormonal status, tumor grade, tumor size, or lymph node status. Univariate Kaplan-Meier log rank analysis showed that patients with high FGF19 expression exhibited a significantly shorter disease-specific 5-year survival (p = 0.007). This effect was exacerbated by lymph node metastasis (p = 0.001), negative estrogen receptor (ER) status (p = 0.002), or old age (p = 0.013). Multivariate analysis showed that high FGF19 expression could be an independent prognostic marker of disease-specific survival in breast cancer patients (p = 0.030). Quantification of FGF19 expression appears to provide valuable prognostic information in breast cancer, particularly in older patients with lymph node metastasis and negative ER status.

Для цитирования: Buhmeida Abdelbaset, Dallol Ashraf, Merdad Adnan, Al-Maghrabi Jaudah, Gari Mamdooh A, Abu-Elmagd Muhammad M, Chaudhary Adeel G, Abuzenadah Adel M, Nedjadi Taoufik, Ermiah Eramah, Al-Thubaity Fatima, Al-Qahtani Mohammed H. High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2013. DOI: 10.1007/s13277-013-1374-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.